Clinical Trial Update: Phase II High-Dose Cyclophosphamide for Multiple Sclerosis [Phase 2]

View source ↗

Summary

A Phase II trial evaluating high-dose cyclophosphamide for multiple sclerosis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Cytoxan (cyclophosphamide)

Snippet

Sponsor: Stony Brook University | Conditions: Multiple Sclerosis | Phase 2 | Status: WITHDRAWN